CN Patent
CN117776973A — 一种4-甲酰基-3-甲氧基苯甲腈的制备方法
Assigned to Shandong Fuchang Pharmaceutical Co ltd · Expires 2024-03-29 · 2y expired
What this patent protects
本发明公开了一种4‑甲酰基‑3‑甲氧基苯甲腈的制备方法。所述方法以式I所示的化合物为原料按照如下反应路线经由五步反应制得4‑甲酰基‑3‑甲氧基苯甲腈。该方法具有条件温和、收率高、成本低廉、环保绿色、适于工业化生产等优点。
USPTO Abstract
本发明公开了一种4‑甲酰基‑3‑甲氧基苯甲腈的制备方法。所述方法以式I所示的化合物为原料按照如下反应路线经由五步反应制得4‑甲酰基‑3‑甲氧基苯甲腈。该方法具有条件温和、收率高、成本低廉、环保绿色、适于工业化生产等优点。
Drugs covered by this patent
- Nubeqa (darolutamide) · Bayer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.